The AFP model identified a subset of HCC patients exceeding Milan criteria, with AFP levels of <100 ng/mL at low risk of recurrence and with 5-year survival rates close to 70% and a subset of patients within Milan criteria, with serum AFP values greater than 1000 ng/mL at high risk of recurrence and significantly shorter survival [36]. This evidence concerns the gene AFP and hepatocellular carcinoma.